Mark For: CATAMARAN™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88858003 |
Mark Literal Elements | CATAMARAN |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED 2020-06-25 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jessica L Rothstein |
Attorney Docket Number | 143456304433 |
2020-04-02 | Application Filed |
2020-04-06 | Location: NEW APPLICATION PROCESSING |
2020-04-06 | Status: Live/Pending |
2020-04-06 | Transaction Date |
2020-06-25 | Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED |
2020-06-25 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
Party: | Catamaran Bio, Inc. |
Address | c/o SV Health Investors 201 Washington Street, Suite 3900 Boston, MASSACHUSETTS UNITED STATES 02108 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Application | MULTI | 2020-04-02 |
Drawing | JPEG | 2020-04-02 |
XSearch Search Summary | XML | 2020-06-22 |
Offc Action Outgoing | MULTI | 2020-06-25 |
IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations and therapeutic agents for the treatment of diseases and conditions, namely, cancer and immune disorders, inflammatory diseases and disorders, genetic diseases and disorders, and infectious diseases and disorders
IC 042. US 100 101. G & S: pharmaceutical research and development; technical scientific consultation or product development for others in the fields of biotechnology, cell therapy and development of pharmaceuticals and therapeutic agents
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | pharmaceutical preparations and therapeutic agents for the treatment of diseases and conditions, namely, cancer and immune disorders, inflammatory diseases and disorders, genetic diseases and disorders, and infectious diseases and disorders |
Description | Date | Proceeding Number |
---|---|---|
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-25 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-06-25 | 95366 |
NON-FINAL ACTION E-MAILED | 2020-06-25 | 6325 |
ASSIGNED TO EXAMINER | 2020-06-22 | 95366 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-04-09 | |
NEW APPLICATION ENTERED IN TRAM | 2020-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.